Literature DB >> 18664957

Stakeholders' opinions and expectations of the Global Fund and their potential economic implications.

Omar Galárraga1, Stefano M Bertozzi.   

Abstract

OBJECTIVES: To analyse stakeholder opinions and expectations of the Global Fund to Fight AIDS, Tuberculosis, and Malaria, and to discuss their potential economic and financial implications.
DESIGN: The Global Fund commissioned an independent study, the '360 degrees Stakeholder Survey', to canvas feedback on the organization's reputation and performance with an on-line survey of 909 respondents representing major stakeholders worldwide. We created a proxy for expectations based on categorical responses for specific Global Fund attributes' importance to the stakeholders and current perceived performance.
METHODS: Using multivariate regression, we analysed 23 unfulfilled expectations related to: resource mobilization; impact measurement; harmonization and inclusion; effectiveness of the Global Fund partner environment; and portfolio characteristics. The independent variables are personal and regional-level characteristics that affect expectations.
RESULTS: The largest unfulfilled expectations relate to: mobilization of private sector resources; efficiency in disbursing funds; and assurance that people affected by the three diseases are reached. Stakeholders involved with the fund through the country coordinating mechanisms, those working in multilateral organizations and persons living with HIV are more likely to have unfulfilled expectations. In contrast, higher levels of involvement with the fund correlate with fulfilled expectations. Stakeholders living in sub-Saharan Africa were less likely to have their expectations met.
CONCLUSIONS: Stakeholders' unfulfilled expectations result largely from factors external to them, but also from factors over which they have influence. In particular, attributes related to partnership score poorly even though stakeholders have influence in that area. Joint efforts to address perceived performance gaps may improve future performance and positively influence investment levels and economic viability.

Entities:  

Mesh:

Year:  2008        PMID: 18664957      PMCID: PMC2810424          DOI: 10.1097/01.aids.0000327618.01362.6a

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

1.  Public health. A global response to AIDS: lessons learned, next steps.

Authors:  Peter Piot; Richard G A Feachem; Jong-Wook Lee; James D Wolfensohn
Journal:  Science       Date:  2004-06-25       Impact factor: 47.728

2.  Scaling up treatment--why we can't wait.

Authors:  Jim Yong Kim; Charlie Gilks
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

3.  An examination of the Global Fund at 5 years.

Authors:  Richard G A Feachem; Oliver J Sabot
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

Review 4.  The 10-year struggle to provide antiretroviral treatment to people with HIV in the developing world.

Authors:  Bernhard Schwartländer; Ian Grubb; Jos Perriëns
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

5.  Absorptive capacity and disbursements by the Global Fund to Fight AIDS, Tuberculosis and Malaria: analysis of grant implementation.

Authors:  Chunling Lu; Catherine M Michaud; Kashif Khan; Christopher J L Murray
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

6.  Health in the developing world: achieving the Millennium Development Goals.

Authors:  Jeffrey D Sachs
Journal:  Bull World Health Organ       Date:  2005-01-05       Impact factor: 9.408

  6 in total
  2 in total

1.  Negative health system effects of Global Fund's investments in AIDS, tuberculosis and malaria from 2002 to 2009: systematic review.

Authors:  Josip Car; Tapio Paljärvi; Mate Car; Ayodele Kazeem; Azeem Majeed; Rifat Atun
Journal:  JRSM Short Rep       Date:  2012-10-15

2.  District Health Officer Perceptions of PEPFAR's Influence on the Health System in Uganda, 2005-2011.

Authors:  Nathaniel Lohman; Amy Hagopian; Samuel Abimerech Luboga; Bert Stover; Travis Lim; Frederick Makumbi; Noah Kiwanuka; Flavia Lubega; Assay Ndizihiwe; Eddie Mukooyo; Scott Barnhart; James Pfeiffer
Journal:  Int J Health Policy Manag       Date:  2017-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.